Modulation of histamine release in vitro by FK506 and interleukin-3 is determined by sequence of incubation

Archives of Dermatological Research

Volumn 289, Issue 10, 1997, Pages 606-608

  Eberlein Konig, Bernadette ^a,c   Michel, Günter ^b   Ruzicka, Thomas ^b   Przybilla, Bernhard ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Basophils; FK506; Histamine; IL 3

Indexed keywords

HISTAMINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 3; TACROLIMUS;

ADULT; ARTICLE; BASOPHIL; FEMALE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADULT; DRUG INTERACTIONS; FEMALE; HISTAMINE RELEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-3; LEUKOCYTES; MIDDLE AGED; TACROLIMUS;

EID: 0030668740     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050248     Document Type: Article

References (13)

1. De Paulis A, Cirillo R, Ciearelli A, de Creseenzo G, Oriente A, Marone G (1991) Characterization of the anti-inflammatory effect of FK-506 on human mast cells. J Immunol 147:4278-4285
2. Do Paulis A, Cirillo R, Condorelli M, Marone G (1991) FK-506, 11 potent novel inhibitor of the release of proinflammatory mediators from human FcεRI+ cells. J Immunol 146:2374-2385
3. DC Paulis A, Stellato C, Cirillo R, Cicarelli A, Oriente A, Marone G (1992) Anti-inflammatory effect of FK-506 on human skin mast cells. J Invest Dermatol 99:723-728
4. Hatfield SM, Mynderse JS, Roehm MW (1992) Rapamycin und FK506 differentially inhibit mast cell cytokine production and cytokine-induecd proliferation and act as reciprocal antagonists. J Pharmacol Exp Ther 261:970-976
5. Hutfield SM, Roehm NW (1992) Cyclosporine and FK506 inhibition of murine mast cell cytokine production. J Pharmacol Exp Ther 260:680-688
6. Eberlein-König B, Ruzicka T, Michel G, Przybilla B (1994) Hemmung der Histaminfreisetzung aus peripheren menschlichen Blutleukozyten durch FK506, ein neues Immunsuppressivum. Allergo J 3:327-330
7. Bang H, Müller W, Hans M, Brune K, Swandulla D (1995) Activation of Ca2+ signaling in neutrophils by the mast cell-release immunophilin FKBP12. Proc Natl Acad Sci USA 92: 3435-3438
8. Okayama Y, Begishvili TB, Church MK (1993) Comparison of mechanism of 1L-3 induced histamine release and IL-3 priming effect on human basophils. Clin Exp Allergy 23:901-910
9. Kurimoto Y, De Weck AL, Dahinden CA (1989) Interleukin 3-dependent mediator release in basophils triggered by C5a. J Exp Med 170:467-479
10. Kurimoto Y, De Weck AL, Dahinden CA (1991) The effect of interleukin 3 upon IgE-dependenl and IgE-independent basophil degranulation and leukotriene generation. Eur J Immunol 21:361-368
11. MacDonald SM, Schleimer RP, Kagey-Sobotka A, Gillis S, Liechtenstein LM (1989) Recombinant IL-3 induces histamine release from human basophils. J Immunol 142:3527-3532
12. Haak-Frendscho M, Aral N, Arai K, Baeza ML, Finn A, Kaplan AP (1988) Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release. J Clin Invest 82:17-20
13. Siraganian RP (1976) Histamine release and assay methods for the study of human allergy. In: Rose NR, Friedmann H (eds) Manual of clinical immunology. American Society for Microbiology, Washington DC, pp 603-615